We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Venn Life Sciences Holdings Plc | LSE:VENN | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.85 | 6.70 | 7.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMHVO
RNS Number : 6840V
hVIVO PLC
06 April 2023
The Company has received the below TR-1 from Cathal Friel. As a result of an increase in the Company's share capital Mr Friel's percentage holding has now fallen from 7.02% to 6.94% of the total issued share capital. However, Mr Friel's total shareholding remains unchanged at 47,087,086 Ordinary Shares.
TR-1: S tandard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) (i) 1a. Identity of the issuer or the hVIVO plc underlying issuer of existing shares to which voting rights are attached (ii) : -------------------------------------------- 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer ---- 2. Reason for the notification (please mark the appropriate box or boxes with an "X") An acquisition or disposal of voting rights ---- An acquisition or disposal of financial instruments ---- An event changing the breakdown of voting rights X ---- Other (please specify)(iii) : ---- 3. Details of person subject to the notification obligation (iv) Name Cathal Friel City and country of registered office (if applicable) 4. Full name of shareholder(s) (if different from 3.) (v) Name -------------------------------------------- City and country of registered office (if applicable) -------------------------------------------- 5. Date on which the threshold was 28/03/2023 crossed or reached (vi) : -------------------------------------------- 6. Date on which issuer notified 06/04/2023 (DD/MM/YYYY): -------------------------------------------- 7. Total positions of person(s) subject to the notification obligation % of voting % of voting rights Total of both Total number rights attached through financial in % (8.A + of voting rights to shares (total instruments 8.B) held in issuer of 8. A) (total of 8.B (vii) 1 + 8.B 2) ------------------ --------------------- -------------- -------------------- Resulting situation on the date on which threshold was crossed or reached 6.94% N/A 6.94% 47,087,086 ------------------ --------------------- -------------- -------------------- Position of previous notification (if applicable) 7.02% N/A 7.02% ------------------ --------------------- -------------- -------------------- 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached (viii) A: Voting rights attached to shares Class/type of Number of voting rights % of voting rights shares (ix) ISIN code (if possible) ---------------------------- -------------------------- Direct Indirect Direct Indirect (DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1) ------------ -------------- ----------- ------------- GB00B9275X97 47,087,086 6.94% ------------ -------------- ----------- ------------- SUBTOTAL 8. A 47,087,086 6.94% ---------------------------- -------------------------- B 1: Financial Instruments according to DTR5.3.1R (1) (a) Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion Period rights that may rights (x) (xi) be acquired if the instrument is exercised/converted. ----------- ------------------- ---------------------- ------------ SUBTOTAL 8. B 1 ------------------- ---------------------- ------------ B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b) Type of financial Expiration Exercise/ Physical Number of % of voting instrument date (x) Conversion or cash voting rights rights Period (xi) settlement (xii) ----------- ------------- ------------ --------------- ------------ SUBTOTAL 8.B.2 ------------ --------------- ------------ 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (xiii) Full chain of controlled undertakings through which the voting X rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (xiv) (please add additional rows as necessary) Name (xvCh) % of voting rights % of voting rights Total of both if it equals or through financial if it equals or is higher than instruments if is higher than the notifiable it equals or is the notifiable threshold higher than the threshold notifiable threshold --------------------- ---------------------- -------------------- 10. In case of proxy voting, please identify: Name of the proxy holder -------------------------------------------- The number and % of voting rights held -------------------------------------------- The date until which the voting rights will be held -------------------------------------------- 11. Additional information (xvi) Place of completion Dublin Date of completion 06/04/2023 -----------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLIFMITMTAMBTJ
(END) Dow Jones Newswires
April 06, 2023 10:54 ET (14:54 GMT)
1 Year Venn Life Sciences Chart |
1 Month Venn Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions